- Home
- FRST vs OCGN Comparison
FRST vs OCGN Comparison
Compare FRST & OCGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FRST
- OCGN
- Stock Information
- Founded
- FRST 2004
- OCGN 2013
- Country
- FRST United States
- OCGN United States
- Employees
- FRST N/A
- OCGN N/A
- Industry
- FRST Major Banks
- OCGN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FRST Finance
- OCGN Health Care
- Exchange
- FRST Nasdaq
- OCGN Nasdaq
- Market Cap
- FRST 300.6M
- OCGN 246.8M
- IPO Year
- FRST 2006
- OCGN N/A
- Fundamental
- Price
- FRST $12.26
- OCGN $0.80
- Analyst Decision
- FRST Buy
- OCGN Strong Buy
- Analyst Count
- FRST 1
- OCGN 3
- Target Price
- FRST $14.00
- OCGN $5.67
- AVG Volume (30 Days)
- FRST 66.5K
- OCGN 3.8M
- Earning Date
- FRST 01-23-2025
- OCGN 11-08-2024
- Dividend Yield
- FRST 3.21%
- OCGN N/A
- EPS Growth
- FRST N/A
- OCGN N/A
- EPS
- FRST N/A
- OCGN N/A
- Revenue
- FRST $104,308,000.00
- OCGN $4,700,000.00
- Revenue This Year
- FRST N/A
- OCGN N/A
- Revenue Next Year
- FRST $12.45
- OCGN N/A
- P/E Ratio
- FRST N/A
- OCGN N/A
- Revenue Growth
- FRST N/A
- OCGN N/A
- 52 Week Low
- FRST $9.52
- OCGN $0.37
- 52 Week High
- FRST $13.69
- OCGN $2.11
- Technical
- Relative Strength Index (RSI)
- FRST 49.97
- OCGN 36.72
- Support Level
- FRST $12.25
- OCGN $0.81
- Resistance Level
- FRST $12.50
- OCGN $0.89
- Average True Range (ATR)
- FRST 0.18
- OCGN 0.05
- MACD
- FRST -0.04
- OCGN -0.01
- Stochastic Oscillator
- FRST 27.50
- OCGN 4.35
About FRST Primis Financial Corp.
Primis Financial Corp is the bank holding company for Primis Bank, providing financial services to individuals and small and medium-sized businesses. Primis Bank offers a wide range of commercial banking services, it focuses on making loans secured majorly by commercial real estate and other types of secured and unsecured commercial loans to small and medium-sized businesses in a number of industries, as well as loans to individuals for a variety of purposes. Primis Bank offers a broad range of deposit products, including checking (NOW), savings, money market accounts and certificates of deposit.
About OCGN Ocugen Inc.
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").